Loading...

Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients: Primary Results from the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial

BACKGROUND: Kidney transplant recipients, like other patients with chronic kidney disease (CKD), experience excess risk of cardiovascular disease (CVD) and elevated total homocysteine (tHcy) concentrations. Observational studies of patients with CKD suggest increased homocysteine is a risk factor fo...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Circulation
Main Authors: Bostom, Andrew G., Carpenter, Myra A., Kusek, John W., Levey, Andrew S., Hunsicker, Lawrence, Pfeffer, Marc A., Selhub, Jacob, Jacques, Paul F., Cole, Edward, Gravens-Mueller, Lisa, House, Andrew A., Kew, Clifton, McKenney, Joyce L., Pacheco-Silva, Alvaro, Pesavento, Todd, Pirsch, John, Smith, Stephen, Solomon, Scott, Weir, Matthew
Format: Artigo
Sprog:Inglês
Udgivet: 2011
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4887854/
https://ncbi.nlm.nih.gov/pubmed/21482964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.110.000588
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!